IMMUNEONCO BIOPHARMACEUTICALS (SHANGHAI) INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.42 HKD | -1.64% |
|
-0.69% | -51.77% |
| Jun. 03 | ImmuneOnco Biopharmaceuticals Gets China's Phase 3 Trial Approval for Leukemia Drug | MT |
| May. 30 | ImmuneOnco Completes Filing with China Regulator for Conversion of H Shares | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IMMUNEONCO BIOPHARMACEUTICALS (SHANGHAI) INC. | Bio Therapeutic Drugs | -1.64% | -0.69% | -51.77% | - | - | 702M |  |  | |
